HUE041873T2 - N-{4-klór-2-hidroxi-3-[(3S)-3-piperidinilszulfonil]-fenil}-N'-(3-fluor-2-metilfenil)-karbamid hidrokloridsója - Google Patents
N-{4-klór-2-hidroxi-3-[(3S)-3-piperidinilszulfonil]-fenil}-N'-(3-fluor-2-metilfenil)-karbamid hidrokloridsójaInfo
- Publication number
- HUE041873T2 HUE041873T2 HUE14799988A HUE14799988A HUE041873T2 HU E041873 T2 HUE041873 T2 HU E041873T2 HU E14799988 A HUE14799988 A HU E14799988A HU E14799988 A HUE14799988 A HU E14799988A HU E041873 T2 HUE041873 T2 HU E041873T2
- Authority
- HU
- Hungary
- Prior art keywords
- piperidinylsulfonyl
- methylphenyl
- fluoro
- chloro
- urea
- Prior art date
Links
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4462—Non condensed piperidines, e.g. piperocaine only substituted in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/452—Piperidinium derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1320021.7A GB201320021D0 (en) | 2013-11-13 | 2013-11-13 | Novel Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE041873T2 true HUE041873T2 (hu) | 2019-05-28 |
Family
ID=49818555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14799988A HUE041873T2 (hu) | 2013-11-13 | 2014-11-11 | N-{4-klór-2-hidroxi-3-[(3S)-3-piperidinilszulfonil]-fenil}-N'-(3-fluor-2-metilfenil)-karbamid hidrokloridsója |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US9809540B2 (enExample) |
| EP (1) | EP3068763B1 (enExample) |
| JP (1) | JP6401265B2 (enExample) |
| KR (1) | KR20160083950A (enExample) |
| CN (1) | CN105683162A (enExample) |
| AU (1) | AU2014350334B2 (enExample) |
| BR (1) | BR112016010409A8 (enExample) |
| CA (1) | CA2929907A1 (enExample) |
| CY (1) | CY1121581T1 (enExample) |
| DK (1) | DK3068763T3 (enExample) |
| ES (1) | ES2714721T3 (enExample) |
| GB (1) | GB201320021D0 (enExample) |
| HR (1) | HRP20190449T1 (enExample) |
| HU (1) | HUE041873T2 (enExample) |
| LT (1) | LT3068763T (enExample) |
| ME (1) | ME03328B (enExample) |
| PL (1) | PL3068763T3 (enExample) |
| PT (1) | PT3068763T (enExample) |
| RS (1) | RS58382B1 (enExample) |
| RU (1) | RU2685408C1 (enExample) |
| SI (1) | SI3068763T1 (enExample) |
| SM (1) | SMT201900156T1 (enExample) |
| TR (1) | TR201902981T4 (enExample) |
| WO (1) | WO2015071235A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015260841A1 (en) * | 2014-05-12 | 2016-12-01 | Glaxosmithkline Intellectual Property (No. 2) Limited | Pharmaceutical compositions comprising danirixin for treating infectious diseases |
| US20180369135A1 (en) * | 2015-11-30 | 2018-12-27 | Glaxosmithkline Intellectual Property (No.2) Limited | Formulations for intravenous administration |
| WO2018073248A1 (en) | 2016-10-17 | 2018-04-26 | Icm (Institut Du Cerveau Et De La Moelle Épinière) | Prognosis of demyelinating diseases patients and treatment thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5269763B2 (ja) | 2006-04-21 | 2013-08-21 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | Ｉｌ−８受容体アンタゴニスト |
-
2013
- 2013-11-13 GB GBGB1320021.7A patent/GB201320021D0/en not_active Ceased
-
2014
- 2014-11-11 LT LTEP14799988.2T patent/LT3068763T/lt unknown
- 2014-11-11 KR KR1020167015530A patent/KR20160083950A/ko not_active Withdrawn
- 2014-11-11 SM SM20190156T patent/SMT201900156T1/it unknown
- 2014-11-11 PL PL14799988T patent/PL3068763T3/pl unknown
- 2014-11-11 EP EP14799988.2A patent/EP3068763B1/en active Active
- 2014-11-11 RU RU2016116955A patent/RU2685408C1/ru not_active IP Right Cessation
- 2014-11-11 SI SI201431125T patent/SI3068763T1/sl unknown
- 2014-11-11 CN CN201480061455.2A patent/CN105683162A/zh active Pending
- 2014-11-11 ES ES14799988T patent/ES2714721T3/es active Active
- 2014-11-11 RS RS20190230A patent/RS58382B1/sr unknown
- 2014-11-11 CA CA2929907A patent/CA2929907A1/en not_active Abandoned
- 2014-11-11 DK DK14799988.2T patent/DK3068763T3/en active
- 2014-11-11 JP JP2016529894A patent/JP6401265B2/ja not_active Expired - Fee Related
- 2014-11-11 PT PT14799988T patent/PT3068763T/pt unknown
- 2014-11-11 BR BR112016010409A patent/BR112016010409A8/pt not_active IP Right Cessation
- 2014-11-11 WO PCT/EP2014/074222 patent/WO2015071235A1/en not_active Ceased
- 2014-11-11 TR TR2019/02981T patent/TR201902981T4/tr unknown
- 2014-11-11 HU HUE14799988A patent/HUE041873T2/hu unknown
- 2014-11-11 ME MEP-2019-47A patent/ME03328B/me unknown
- 2014-11-11 US US15/034,583 patent/US9809540B2/en not_active Expired - Fee Related
- 2014-11-11 AU AU2014350334A patent/AU2014350334B2/en not_active Ceased
- 2014-11-11 HR HRP20190449TT patent/HRP20190449T1/hr unknown
-
2017
- 2017-10-05 US US15/725,429 patent/US20180079722A1/en not_active Abandoned
-
2018
- 2018-12-13 US US16/218,602 patent/US10604485B2/en not_active Expired - Fee Related
-
2019
- 2019-02-26 CY CY20191100237T patent/CY1121581T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014350334B2 (en) | 2017-08-10 |
| SMT201900156T1 (it) | 2019-05-10 |
| AU2014350334A1 (en) | 2016-06-02 |
| BR112016010409A8 (pt) | 2020-04-22 |
| ME03328B (me) | 2019-10-20 |
| SI3068763T1 (sl) | 2019-04-30 |
| CN105683162A (zh) | 2016-06-15 |
| LT3068763T (lt) | 2019-03-12 |
| US20180079722A1 (en) | 2018-03-22 |
| CY1121581T1 (el) | 2020-05-29 |
| RU2016116955A (ru) | 2017-12-19 |
| RS58382B1 (sr) | 2019-04-30 |
| TR201902981T4 (tr) | 2019-03-21 |
| PT3068763T (pt) | 2019-03-20 |
| RU2685408C1 (ru) | 2019-04-18 |
| EP3068763A1 (en) | 2016-09-21 |
| PL3068763T3 (pl) | 2019-05-31 |
| JP6401265B2 (ja) | 2018-10-10 |
| US9809540B2 (en) | 2017-11-07 |
| US20160264525A1 (en) | 2016-09-15 |
| US20190112269A1 (en) | 2019-04-18 |
| CA2929907A1 (en) | 2015-05-21 |
| KR20160083950A (ko) | 2016-07-12 |
| US10604485B2 (en) | 2020-03-31 |
| DK3068763T3 (en) | 2019-03-18 |
| ES2714721T3 (es) | 2019-05-29 |
| GB201320021D0 (en) | 2013-12-25 |
| HRP20190449T1 (hr) | 2019-04-19 |
| WO2015071235A1 (en) | 2015-05-21 |
| JP2016537344A (ja) | 2016-12-01 |
| EP3068763B1 (en) | 2018-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL243200A0 (en) | Converted analogs of (e)-n'-(1-phenylethylidene)benzohydrazide as histone demethylase inhibitors | |
| IL244943B (en) | History of n-[3-(5-oxy-6-amino-pyrimidin-4-yl)phenyl]benzamide and pharmaceutical preparations that include them | |
| IL242278A (en) | Compounds n- (4-Fluoro-2-Methoxy-5-Nitrophenyl) Pyrimidine-2-Reliable Conjugated Salts | |
| IL240196A0 (en) | Amide compounds, compositions comprising same and uses thereof | |
| HUE036582T2 (hu) | Nitrogéntartalmú heterociklusos vegyület vagy annak sója | |
| IL248240A0 (en) | Compounds containing carbazole-amide, carbamate and urea, preparations containing them and their uses | |
| PL3059227T3 (pl) | Sól heterocyklicznego związku zawierającego azot lub jej kryształ, kompozycja farmaceutyczna i inhibitor flt3 | |
| EP2970418A4 (en) | STABILIZED EZH2 PEPTIDES | |
| IL244813A0 (en) | A compound with agonistic activity for the somatostatin receptor and its medicinal use | |
| EP2934526A4 (en) | ANTIMICROBIAL BISPYRIDINAMINE COMPOSITIONS AND USES | |
| EP2906221A4 (en) | NITROGEN AND AMID DERIVATIVES OF AMINOALKYLPIPERAZINES AND THEIR USE | |
| IL255751A (en) | Benzamide, the preparations of the active compound and methods of use | |
| ZA201503246B (en) | N-(2-(cyclic amine)ethyl)benzamide derivatives as p2x7 inhibitors | |
| IL256527A (en) | Aryl sulfonamide compounds as carbonic anhydrase inhibitors and their medical use | |
| EP2902391A4 (en) | NOVEL AMINE COMPOUND AND USE THEREOF | |
| IL232404A0 (en) | n-(4-quinolinylmethyl)-sulfonamide derivatives and their use as anthelmintics | |
| ZA201601666B (en) | Heterocyclic amide compound and herbicide | |
| SMT201900156T1 (it) | Sale bromidrato di n-(4-cloro-2-idrossi-3-((3s)-3-piperidinilsolfonil)fenil)-n'-(3-fluoro-2-metilfenil)urea | |
| EP2842937A4 (en) | AMIN CONNECTION AND USE THEREOF FOR MEDICAL PURPOSES | |
| IL266861A (en) | Benzamide and active compound preparations and methods of use | |
| IL238529A0 (en) | Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof | |
| EP2680846A4 (en) | USE OF N- (4-METHOXYPHENYL) -1-PHENYL-1H-PYRAZOL-3-AMINE AND COMPOUNDS ASSOCIATED THEREWITH | |
| IL237432B (en) | Amine salt, its crystals and pharmaceutical preparations containing it | |
| HUE046959T2 (hu) | Eljárás N-(3,5-dimetilfenil)-N'-(2-trifluormetilfenil) guanidin elõállítására | |
| TH1501001044A (th) | เกลือแอมีน และผลึกของสารนั้น |